MEDESIS PHARMA PRESENTS A SCIENTIFIC POSTER AT THE CLINICAL TRIALS ON ALZHEIMER\'S DISEASE CONFERENCE IN SAN FRANCISCO

28 Nov 2022 18:00 CET

Issuer

MEDESIS PHARMA S.A.

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1121951_MEDESIS_PHARMA_CP_CTADNovembre2022_EN.pdf

Source

MEDESIS PHARMA

Provider

Les Echos

Company Name

MEDESIS PHARMA S.A.

ISIN

FR0010844464

Symbol

ALMDP

Market

Euronext Growth